Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Notice To Shareholders For Transfer Of Equity Shares & Unclaimed Dividend To Investor Education & Protection Fund (IEPF)Account Published In Newspapers

 Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of the newspaper notice published in The Free Press Journal (English) and Navshakti (Regional) newspapers on February 01, 2020 for attention of Shareholders in respect of transfer of unclaimed interim dividend and corresponding equity shares of the Company to Investor Education and Protection Fund ("IEPF") for the financial year 2012-2013 in accordance with the provisions of the Companies Act, 2013 read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time. The aforesaid advertisement is also available on the website of the Company at www.blissgvs.com.
01-02-2020
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Tuesday, February 11, 2020 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2019 published in ''The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on February 01, 2020. Kindly take the same on record.
01-02-2020
Bigul

Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31, 2019

 BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2020 ,inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2019. Further, pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from January 01, 2020 and shall remain closed till 48 hours after the announcement of the Financial Results i.e. up to Thursday, February 13, 2020. Kindly acknowledge and take on record the same.
31-01-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Statement Of Investor Complaints For The Quarter Ended December 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0101 Name of the Signatory :- Aditi BhattDesignation :- Company Secretary and Compliance Officer
20-01-2020
Bigul

Bliss GVS Pharma Ltd - 506197 - Shareholding for the Period Ended December 31, 2019

 Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
15-01-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2019.
08-01-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window

 This is with reference to the Circular no. LIST/COMP/01/2019-20 and NSE/CML/2019/11 dated April 02, 2019 issued by BSE Limited and National Stock Exchange of India Limited respectively pertaining to clarification regarding trading restriction period read with the SEBI (Prohibition of Insider Trading) (Second Amendment) Regulations, 2019 dated July 25, 2019 issued by SEBI and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, we wish to inform you that, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') will remain closed for all the Designated Persons and their immediate relatives of the Company with effect from Wednesday, January 01, 2020 until 48 hours after the announcement of the un-audited financial results of the Company for the quarter and nine months ended December 31, 2019.
31-12-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder.
07-12-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Dear Sir/Madam, Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed disclosure of Related Party Transactions on the basis on consolidated financial statements for the half year ended September 30, 2019. Kindly take the above information on record.
02-12-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the second quarter and half year ended September 30, 2019 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on November 13, 2019. Kindly take the same on record.
13-11-2019
Next Page
Close

Let's Open Free Demat Account